Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Avicanna Inc (OP: AVCNF )

0.2082 UNCHANGED
Streaming Delayed Price Updated: 2:56 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avicanna Inc

< Previous 1 2 3 4 Next >
Avicanna Reveals The Initial Network Of Brands On Its Cannabis Care Platform
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products announced its... 
Via Benzinga
Cannabis Stock Gainers And Losers From July 25, 2023
Via Benzinga
European Cannabis Q2 2023 Quarterly Update
Country access schemes were simmering in the EU. Pressure continues to build from patients and advocates to increase access to cannabis. 
Via Talk Markets
Avicanna Launches Water-Soluble THC Infuser
Avicanna Inc. 
Via Benzinga
Avicanna Announces Extension Of Term Loan
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) has entered into a extension agreement in connection with its senior secured term loan previously announced on August 19, 2021. 
Via Benzinga
Avicanna's SMGH Exports Aureus Branded CBD And CBG Into Paraguay
Santa Marta Golden Hemp, a majority owned subsidiary of Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) has completed the commercial export of Aureus branded products into Paraguay. 
Via Benzinga
Two Pot Companies Continue To Focus On Cannabinoid-Based Self-Emulsifying Drug Delivery Systems
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) announced the extension of its existing strategic manufacturing agreement with Medipharm Labs Inc. (OTCQB: MEDIF) for the commercialization of... 
Via Benzinga
Avicanna Sponsors New Medical Cannabis Education And Training Campaign In Canada
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) has entered into a sponsorship agreement with the Canadian Consortium for the Investigation of Cannabinoids (“CCIC”) to sponsor CICC in making... 
Via Benzinga
Avicanna And Langara College Team Up For Cannabinoid-Based Translational Research
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) has entered a research collaboration with the Applied Research Centre at Langara College that will focus on Avicanna’s proprietary formulations and... 
Via Benzinga
Shoppers Drug Mart Signs Definitive Cannabis Asset Sale Agreement With Avicanna
In a pivotal move in the biopharmaceutical industry, Avicanna Inc. 
Via Benzinga
These 3 Experts Will Help Regulate Rhode Island's Marijuana Market & Other Cannabis Appointments
RI Gov. Elects 3 Experts To Keep Rhode Island's Cannabis Market Regulated & Licensed 
Via Benzinga
Avicanna And Northern Green Canada Execute Master Service Agreement To Operationalize MyMedi.ca
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) has entered into a master service agreement with Northern Green Canada to operationalize MyMedi.ca medica 
Via Benzinga
Avicanna FY22 Revenue Grows 24%, Here Is What You Need To Know
Avicanna Inc. (TSX:AVCN) (OTCQX: AVCNF) (FSE:0NN) total fiscal 2022 revenue of CA$4 million representing growth of 24% from CA$3.3 million in fiscal 2021. 
Via Benzinga
Avicanna Stock Jumps On Partnership With Shoppers Drug Mart
Shoppers Drug Mart has selected Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) as its partner to transition its Medical Cannabis by Shoppers business. 
Via Benzinga
Historic Ruling To Legalize Cannabis Cultivation In Brazil: These Weed Companies Will Likely Benefit
Following years of stalling on the issue of legal cultivation of cannabis for medicinal and industrial purposes, a Brazilian appeals court is set to rule on allowing businesses and farmers to... 
Via Benzinga
Avicanna Secures $908K Via Private Placement
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) has closed a non-brokered private placement offering of 3.1 million ‎‎units of the company at a price of CA$0.40 per unit for aggregate gross proceeds... 
Via Benzinga
The Intersection Of Cannabis & Consumer Products: These Non-Cannabis Companies Are Benefiting From The Growing Industry
Cannabis stocks have struggled in the market in recent years. But while the cannabis industry itself is still struggling to gain ground on the regulatory front, plenty of companies outside the industry... 
Via Benzinga
Avicanna Expands Its Pact With Al Harrington's Viola Brands To The UK
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) has entered into a new sub-license agreement with VB Brands California LLC and Player Holdings LLC to exclusively commercialize its Viola-branded... 
Via Benzinga
Avicanna To Slash Prices Of Its Warrants And Debentures, Delay Maturity Date
Avicanna Inc. (OTCQX: AVCNF) (TSX: AVCN) (FSE: 0NN) has entered agreements with the holders of convertible debentures bearing an aggregate principal amount of $1.94 million and a maturity date of... 
Via Benzinga
Avicanna Completes First Commercial Export Of Feminized Cannabis Seeds To Spain
Biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) has completed its first commercial export of feminized cannabis seeds to Spain. The export was done through the company's... 
Via Benzinga
Avicanna Promotes Phillip Cardella To CFO, Secures $1.77M Via Private Placement
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) announced the promotion of Phillip Cardella to CFO. Cardella has served as the company’s interim CFO since May 2022. 
Via Benzinga
These Two Companies Plan To Do A Real-World Evidence Study On Efficacy Of CBG Transdermal Gel On Pain And Inflammation
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) will be initiating an observational real-world evidence study using RHO Phyto branded Cannabigerol (“CBG”) transdermal gel on patients with... 
Via Benzinga
NBA Star Al Harrington Unveils Edibles Inspired By Foods He Enjoyed In 'Grandma's Kitchen'
Viola Brands, the cannabis company from NBA star Al Harrington, is expanding its offerings with Grandma-themed edibles, according to Yahoo Finance. 
Via Benzinga
Avicanna Secures $627K Via Private Placement
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) has closed a non-brokered private placement offering of 1.8 million ‎‎units of the company at a price of $0.35 per unit 
Via Benzinga
Avicanna Formalizes Its Patent Application For Cannabinoid-Based Epilepsy Medication
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN), has formalized its provisional patent application, entitled "Methods for Reducing or Eliminating Incidence of Seizures and Sudden Unexpected Death in... 
Via Benzinga
Avicanna Launches A Medical Cannabis Education Portal For Health Care Professionals
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) has launched its medical cannabis education portal, ”Avicenna Academy”, a no-cost resource and medical education portal for health care professionals. 
Via Benzinga
Avicanna Expands Its Cannabinoid Based Drug For Epilepsy Research Program In Partnership With The University Of Toronto
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, has... 
Via Benzinga
These 9 Cannabis Companies Are Leading The Way In Latin America: What Are They Up To And Why Should You Pay Attention?
The Benzinga Cannabis Capital Conference in Chicago, September 13-14, will celebrate the most recognized Latin American cannabis companies. 
Via Benzinga
Avicanna Reports Q2 2022 Earnings: Over 100% Increase From Last Year, Meet CEO At Benzinga Cannabis Capital Conference
Avicanna (OTCQX: AVCNF), a biopharmaceutical company focused on cannabinoid-based products, released its Q2 2022 highlights: 
Via Benzinga
Sun, Water, Weed And B2B?: What Opportunities Can Cannabis Investors Expect From This Conference In Panama
By Franca Quarneti via El Planteo. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.